The goal of this activity is for learners to be better able to evaluate the current and emerging landscape for the treatment of ATTR-CM, including understanding of the role of genetics in therapeutic targets as well as the value of prognostic markers of treatment success and implications for improved patient outcomes.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/transforming-perspectives-transthyretin-amyloid-2024a1000llc/
- Start Date: 2024-12-05 06:00:00
- End Date: 2024-12-05 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
Nursing: 0.75 hours - MOC Credit Details: ABIM - 0.75 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Bridge Bio - Amount: 73583.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Cardiovascular Disease
Subscribe
Login
0 Comments
Oldest